Drug profile · INN
nilotinib d-tartrate
NILOTINIB D-TARTRATE
nilotinib d-tartrate (NILOTINIB D-TARTRATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — nilotinib d-tartrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
nilotinib d-tartrate (NILOTINIB D-TARTRATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is nilotinib d-tartrate?
nilotinib d-tartrate (NILOTINIB D-TARTRATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nilotinib d-tartrate?
NILOTINIB D-TARTRATE is a marketed brand name for nilotinib d-tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nilotinib d-tartrate?
nilotinib d-tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.